Medication for Delirium Tremens
Benzodiazepines are the definitive first-line treatment for delirium tremens, with diazepam or lorazepam as the preferred agents, administered in doses adequate to control symptoms and prevent mortality. 1, 2
Primary Treatment: Benzodiazepines
Benzodiazepines form the cornerstone of delirium tremens management because they directly address the underlying neurochemical imbalance—specifically the GABA-glutamate dysregulation that drives the hyperexcitability and life-threatening autonomic instability characteristic of this condition 3, 2.
Preferred benzodiazepine selection:
- Diazepam or lorazepam are the agents of choice 2
- Selection depends on clinical context (hepatic function, need for predictable metabolism, route of administration)
- Dosing must be aggressive and symptom-driven—underdosing is a common pitfall that leads to treatment failure
The ESMO guidelines explicitly state that benzodiazepines are the treatment of choice as monotherapy for alcohol withdrawal 1. This is critical: delirium tremens is fundamentally alcohol withdrawal delirium, not general ICU delirium, and the treatment approach differs substantially.
Critical Distinction: DT vs. General ICU Delirium
Do NOT confuse delirium tremens with general ICU delirium. The ICU delirium guidelines 4 explicitly recommend AGAINST routine benzodiazepine use for non-withdrawal delirium and even suggest dexmedetomidine over benzodiazepines in that context. However, these same guidelines make a crucial exception: "in adult ICU patients with delirium unrelated to alcohol or benzodiazepine withdrawal" 4. This language confirms that alcohol withdrawal delirium (delirium tremens) requires benzodiazepines.
Adjunctive Medications
Haloperidol may be added to benzodiazepines specifically to control hallucinations and severe agitation 5, but it is adjunctive, not primary therapy. The starting dose is typically 0.5-1 mg PO or SC, with careful monitoring for QTc prolongation 1.
High-dose parenteral thiamine (Vitamin B1) and magnesium must be administered immediately in all cases of severe alcohol withdrawal to prevent Wernicke encephalopathy, which cannot be reliably differentiated from delirium tremens clinically 5.
Refractory Cases
When patients fail to respond to escalating benzodiazepine doses (benzodiazepine-refractory delirium tremens), consider:
- Phenobarbital 2
- Propofol infusion 2, 6—case series demonstrate efficacy in patients refractory to high-dose benzodiazepines
- Dexmedetomidine 7, 2—emerging as an option for prolonged cases
These agents require ICU-level monitoring and should be considered when benzodiazepine requirements become dangerously high or ineffective 7.
Key Monitoring Requirements
- Vital signs continuously due to autonomic dysregulation
- Electrolyte panels with aggressive correction of imbalances
- QTc interval if using antipsychotics
- Fluid status with appropriate resuscitation
- Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) to guide dosing 8
Common Pitfalls to Avoid
- Underdosing benzodiazepines out of fear—this is the most dangerous error. Adequate symptom control prevents mortality
- Using antipsychotics as monotherapy—they do not address the underlying pathophysiology and can worsen outcomes
- Applying general ICU delirium guidelines to DT—these are fundamentally different conditions requiring opposite approaches to benzodiazepines
- Failing to give thiamine—always assume concurrent Wernicke risk
- Delaying ICU transfer—DT has 15% mortality and requires intensive monitoring 6
Special Considerations in Older Adults
Patients ≥65 years require particular vigilance as they experience earlier symptom onset, greater sensitivity to both withdrawal and treatment, and higher complication rates due to decreased neurological reserve 8. Start with lower doses but titrate aggressively to effect, monitoring closely for oversedation.